Funding Rounds
TOLREMO therapeutics

TOLREMO therapeutics Seed (2017, $2M)

TOLREMO therapeutics

Developer of small molecules to treat novel drug resistance pathways in cancer therapy.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $2.60M